MarketPeel
Insider Trading Intelligence
Pricing
…
CL

Column Group Iii, Lp

TNYA
10% OWNER · TENAYA THERAPEUTICS, INC. · CIK 0001668159
FILING MIX · LIFETIME66%/34%
BUYS
59
SELLS
31
TOTAL VALUE
$168.26M
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
3,445,838
AVG SELL PX
$6.98
TRADE KIND
SHOWING 90 / 90
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
45 backtested trades · 8 horizons · 73 pending
Forward-return performance of every backtestable P/S trade by Column Group Iii, Lp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d45+68.89%+2.51%-0.44%+2.95%-3.12%1.67
14d45+31.11%+3.53%-1.93%+5.46%-7.84%1.46
30d45+17.78%+7.46%-2.45%+9.91%-2.76%2.68
60d45+48.89%+0.73%+1.58%-0.85%-2.17%-0.27
90d45+22.22%+16.47%+5.31%+8.40%-10.83%1.37
180d45(16 pending)+65.52%+21.01%+14.38%+4.24%-2.83%—
1y45(22 pending)+56.52%+90.64%+7.49%+83.15%+149.21%—
2y45(35 pending)+100.00%+145.98%+29.45%+116.53%+116.53%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TNYA · 0 shares · as of Feb 25, 2026
012,328,39024,656,78036,985,16949,313,55920222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 59 buys / 31 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TNYA
TENAYA THERAPEUTICS, INC.
SALE
1,862,545$0.56$1.05M0Feb 25, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
1,649,281$0.56$927.6K0Feb 25, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
309,228$0.62$190.3K1,649,281Feb 24, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
349,212$0.62$214.9K1,862,545Feb 24, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
143,709$0.60$85.8K1,958,509Feb 23, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
162,291$0.60$96.9K2,211,757Feb 23, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
245,965$0.61$151.2K2,102,218Feb 20, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
277,769$0.61$170.8K2,374,048Feb 20, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
1,905,115$0.68$1.30M2,348,183Feb 11, 2026Feb 12, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
2,151,458$0.68$1.46M2,651,817Feb 11, 2026Feb 12, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
182,295$0.82$148.8K4,803,275Feb 10, 2026Feb 12, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
161,422$0.82$131.7K4,253,298Feb 10, 2026Feb 12, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
8,484$19.60$166.3K900,292Jan 20, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
9,568$19.60$187.5K1,016,658Jan 20, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
1,358$20.00$27.2K1,007,090Jan 16, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
1,204$20.00$24.1K891,808Jan 16, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
5,590$19.89$111.2K890,604Jan 15, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
6,303$19.89$125.4K1,005,732Jan 15, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
2,927$19.99$58.5K999,429Jan 14, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
2,596$19.99$51.9K885,014Jan 14, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
5,861$19.80$116.1K882,418Jan 13, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
6,609$19.80$130.9K996,502Jan 13, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
8,003$19.89$159.2K989,893Jan 6, 2026Jan 8, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
7,097$19.89$141.1K876,557Jan 6, 2026Jan 8, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
14,503$19.54$283.4K869,460Dec 5, 2025Dec 8, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
16,381$19.54$320.1K981,890Dec 5, 2025Dec 8, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
2,791$17.35$48.4K965,509Dec 4, 2025Dec 8, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
2,475$17.35$42.9K854,957Dec 4, 2025Dec 8, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
167,307$12.65$2.12M962,718Nov 13, 2025Nov 17, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
148,150$12.65$1.87M852,482Nov 13, 2025Nov 17, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
102,651——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
98,870——98,870Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
344,827$11.60$4.00M344,827Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
111,656——111,656Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
182,884——182,884Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
172,414——172,414Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
352,225——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
548,653——548,653Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
111,656——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
397,773——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
90,897——90,897Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
517,241——517,241Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
102,651——102,651Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
365,769$11.60$4.24M795,411Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
397,773——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
323,886$11.60$3.76M704,332Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
352,225——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
90,897——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
SALE
98,870——0Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
485,830——485,830Mar 26, 2025Mar 28, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
161,943——161,943Mar 26, 2025Mar 28, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
35,714,284——35,714,284Mar 5, 2025Mar 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
35,714,284$0.70$25.00M49,313,559Mar 5, 2025Mar 7, 2025 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
17,857,142——17,857,142Mar 5, 2025Mar 7, 2025 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
102,651$15.50$1.59M326,992Apr 4, 2024Apr 17, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
90,897$15.50$1.41M289,549Apr 4, 2024Apr 17, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
397,773——397,773Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
90,897——90,897Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
98,870——98,870Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
102,651$15.50$1.59M332,885Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
102,651——102,651Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
90,897$15.50$1.41M294,767Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
111,656——111,656Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
352,225——352,225Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
397,773——397,773Apr 4, 2024Apr 8, 2024 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
352,225——352,225Apr 4, 2024Apr 8, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
2,222,222$4.50$10.00M13,599,275Feb 12, 2024Feb 14, 2024 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
6,779$2.60$17.6K11,377,053Mar 10, 2023Mar 14, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
1,500,000$2.60$3.90M11,370,274Feb 8, 2023Feb 10, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
69,739$2.50$174.2K9,870,274Jan 19, 2023Jan 23, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
135,688$2.52$341.4K9,800,535Jan 18, 2023Jan 19, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
49,463$2.49$123.4K9,664,847Jan 17, 2023Jan 19, 2023 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
9,615,384$2.60$25.00M9,615,384Nov 21, 2022Nov 23, 2022 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
188,881——0Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
4,389,282——4,414,720Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
533,781——0Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
4,209,755——0Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
213,306——0Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
472,659——0Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
PURCHASE
4,956,842——4,985,570Aug 3, 2021Aug 3, 2021 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
3,727,742——0Aug 3, 2021Aug 3, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
952,023$36.40$34.65M2,151,026Nov 16, 2020Nov 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
1,075,133$36.40$39.13M2,429,180Nov 16, 2020Nov 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
25,318——25,318Jun 17, 2020Jun 19, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
7,234——7,234Jun 17, 2020Jun 19, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
5,137,583——0Feb 18, 2020Feb 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
99,758——0Feb 18, 2020Feb 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
2,740,043——0Feb 18, 2020Feb 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
7,977,384——7,977,384Feb 18, 2020Feb 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
36,168——36,168Feb 12, 2020Jun 19, 2020 ↗View →
Other insiders · TNYA
Loading peer insiders…
About this filer
CIK 0001668159
ROLE
10% Owner
PRIMARY
TNYA
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001668159DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback